Companion theme of all Swiss Large Cap >$10bn companies, this listing with capitalizations in the range of $2 bn to $10 bn may highlight unfamiliar names and some strong performers
OTC trading volume varies to a great extent - with sectors such as Finance or Healthcare with medical instruments specialist Ypsomed
Since the companies are often very loosely traded on OTC markets, their performance will usually reflect the trend but not the actual performance on their home market, adjusted for currency shifts - their track record on OTC is strictly informative and will justify further research
In the absence of any trade during the past 12-months, Mid Cap firms - such as the various regional banks - have been excluded from the selection
With low trading volume on U.S. OTC markets for the listed shares, performance, volatility and drawdown calculations will be affected - these ratios do not reflect true performance, volatility and drawdown as these same shares are normally traded on their national exchange
Our platform of asset information will include fundamental data information for companies listed on NYSE and NASDAQ, but accounting data for the OTC (over-the-counter) quoted firms is not available
To highlight momentum and check trends, selected a short time frame - from two weeks to six months - on the menu (top right)
Investors are free to bookmark stocks of interest and to test investments in their virtual portfolio